SBB Research Group’s Humana HUM Stock Holding History

SBB Research Group’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-439	Closed	-$213K	–	61
2022 Q3	$213K	Buy	+439	New	+$214K	0.3%	43

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

SBB Research Group's HUM Position: Q4 2022 in Review

SBB Research Group sold out of Humana (HUM) in Q4 2022, closing a stake of 439 shares — an estimated $213K sold.

SBB Research Group first reported a position in HUM in Q3 2022 and held it in 1 quarter. The position peaked at $213K in Q3 2022. 1,077 funds tracked by Wall St. Rank hold HUM as of Q4 2022.

SBB Research Group reported no remaining Humana position as of Q4 2022 after selling out during the quarter.
SBB Research Group sold 439 Humana shares in Q4 2022, an estimated $213K.
SBB Research Group first reported a position in Humana in Q3 2022 and held it in 1 quarter.
SBB Research Group's Humana position peaked at $213K in Q3 2022.
1,077 funds tracked by Wall St. Rank held Humana as of Q4 2022.

Based on SBB Research Group's 13F filing for Q4 2022, filed 9 Feb 2023.